World

Sons of Mexican drug lord 'El Chapo' deny trafficking fentanyl in rare letter

May 05, 2023

Mexico City [Mexico], May 5: Sons of former Mexican drug lord Joaquin "El Chapo" Guzman denied U.S. allegations that they were major traffickers flooding the United States with synthetic opioid fentanyl, addressing the claims against them in a rare letter.
The U.S. Justice Department last month charged leaders of the Sinaloa Cartel with trafficking fentanyl and other drugs, including four sons of El Chapo, the cartel's one time leader who is now imprisoned in the U.S.
The letter was sent on behalf of El Chapo's four indicted sons known as "Los Chapitos," or little Chapos, including Ovidio Guzman, who was captured in Mexico in January and awaits extradition to the United States.
"We have never produced, manufactured or marketed fentanyl or any of its derivatives," the sons wrote in the letter, published by Mexican news outlet Milenio late on Wednesday.
The letter was shared with Milenio by Jose Refugio Rodriguez, who when contacted by Reuters confirmed he is the Guzman family lawyer.
In the letter, the sons say they are not the Sinaloa Cartel's leaders but rather are the victims of an international misinformation campaign by companies, the media and public figures that has painted them to be notorious drug traffickers.
Their letter was in response to a press conference on April 14 in Washington, DC, where senior U.S. officials said the Sinaloa Cartel was the main supplier of illicit fentanyl to the United States.
They also singled out Los Chapitos as key figures in the Sinaloa Cartel, blaming them for worsening the U.S. opioid epidemic.
Mexico and the United States agreed last month to ramp up efforts to stop the trafficking of fentanyl, which has driven a surge in overdose deaths in the United States.
Source: Fijian Broadcasting Corporation

More news

Metropolis Foundation launches the 7th Edition of its Award-winning Flagship CSR Initiative - 'MedEngage Scholarship Programme'

Mumbai (Maharashtra) [India], December 26: Metropolis Foundation, the Corporate Social Responsibility (CSR) arm of Ameera Shah-led Metropolis Healthcare Limited, India's second-largest and most respected pathology laboratory chain, is proud to announce the launch of the 7th edition of its annual 'MedEngage Scholarship Programme 2024-25.' This year, the programme will support 350 medical students with scholarships, including 30 students who will receive research grants. Applications are now open for undergraduate and postgraduate medical students, including those pursuing MBBS in any year, as well as MD/MS/DNB training and the internship year.

Dec 26, 2024